Aytu Biopharma Inc
AYTU2.200USD
+0.070+3.29%
Cierre 11/05, 16:00（ET）Cotizaciones retrasadas 15 min
19.75MCap. mercado
PérdidaP/E TTM
Más Datos de Aytu Biopharma Inc Compañía
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Información de Aytu Biopharma Inc
Símbolo de cotizaciónAYTU
Nombre de la empresaAytu Biopharma Inc
Fecha de salida a bolsaOct 20, 2017
Director ejecutivoMr. Joshua R. (Josh) Disbrow
Número de empleados99
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 20
Dirección7900 E. Union Avenue
CiudadDENVER
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal80237
Teléfono17204376580
Sitio Webhttps://aytubio.com/
Símbolo de cotizaciónAYTU
Fecha de salida a bolsaOct 20, 2017
Director ejecutivoMr. Joshua R. (Josh) Disbrow
Ejecutivos de Aytu Biopharma Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+108.97%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+210.89%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+51.62%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+89.67%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+101.78%
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+108.97%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+210.89%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+51.62%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+89.67%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+101.78%
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
ADHD portfolio
57.58M
86.73%
Pediatric portfolio
8.77M
13.21%
Other
37.00K
0.06%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
ADHD portfolio
57.58M
86.73%
Pediatric portfolio
8.77M
13.21%
Other
37.00K
0.06%
Estadísticas de accionistas
Actualizado: jue., 9 de oct
Actualizado: jue., 9 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
10.67%
Stonepine Capital Management, LLC
7.98%
AWM Investment Company, Inc.
6.08%
Kanen Wealth Management, LLC
5.63%
Lytton (Laurence W)
4.97%
Otro
64.67%
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
10.67%
Stonepine Capital Management, LLC
7.98%
AWM Investment Company, Inc.
6.08%
Kanen Wealth Management, LLC
5.63%
Lytton (Laurence W)
4.97%
Otro
64.67%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
20.71%
Hedge Fund
11.92%
Individual Investor
9.18%
Investment Advisor
0.90%
Bank and Trust
0.03%
Otro
57.27%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
61
3.42M
33.56%
+1.32M
2025Q2
68
3.25M
36.18%
+961.20K
2025Q1
66
2.05M
28.89%
-146.84K
2024Q4
71
2.05M
33.28%
-280.21K
2024Q3
75
2.20M
40.58%
-328.29K
2024Q2
78
2.26M
43.50%
-3.54K
2024Q1
82
1.99M
41.33%
-356.06K
2023Q4
85
1.96M
40.81%
-395.45K
2023Q3
91
1.92M
40.24%
-406.76K
2023Q2
100
1.89M
40.00%
+821.00K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Nantahala Capital Management, LLC
1.09M
10.96%
--
--
Jun 30, 2025
Stonepine Capital Management, LLC
812.68K
8.2%
+348.95K
+75.25%
Jun 30, 2025
AWM Investment Company, Inc.
619.87K
6.25%
+619.87K
--
Jun 30, 2025
Kanen Wealth Management, LLC
573.36K
5.78%
+407.09K
+244.84%
Jun 30, 2025
Lytton (Laurence W)
506.61K
5.11%
+506.61K
--
Jun 09, 2025
Disbrow (Joshua R.)
153.26K
1.71%
+66.67K
+76.99%
Jun 09, 2025
Renaissance Technologies LLC
89.91K
0.91%
+13.09K
+17.04%
Jun 30, 2025
Disbrow (Jarrett T)
29.46K
0.33%
+16.67K
+130.24%
Jun 09, 2025
Geode Capital Management, L.L.C.
53.87K
0.54%
-75.00
-0.14%
Jun 30, 2025
Selhorn (Ryan J)
16.00K
0.26%
--
--
Mar 24, 2025
Ver más
ETFs relacionados
Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
DFA Dimensional US Sustainability Core 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Fecha
Tipo
Relación
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
